Inhibition of growth hormone action in models of inflammation

American Journal of Physiology - Cell Physiology

Volumn 279, Issue 6 48-6, 2000, Pages

  Bergad, Pearl L ^a   Schwarzenberg, Sarah Jane ^a   Humbert, Jeffrey T ^a   Morrison, Michelle ^a   Amarasinghe, Sherani ^b   Towle, Howard C ^b   Berry, Susan A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Lipopolysaccharide; Rat liver; Serine protease inhibitors 2.1 and 2.2; Signal transducers and activators of transcription proteins

Indexed keywords

GROWTH HORMONE; LIPOPOLYSACCHARIDE; MESSENGER RNA; SERINE PROTEINASE INHIBITOR; STAT3 PROTEIN; STAT5 PROTEIN;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA RESPONSIVE ELEMENT; HORMONAL REGULATION; HORMONE ACTION; HORMONE INHIBITION; HYPOPHYSECTOMY; INFLAMMATION; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0033635102     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.2000.279.6.c1906     Document Type: Article

References (71)

1. Growth hormone preferentially induces the rapid, transient expression of SOCS- 3, a novel inhibitor of cytokine receptor signaling
2. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway
3. Stimulation of hepatic acute phase response by cytokines and glucocorticoids
4. Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two γ-activated sites
5. Regulation of Spi 2.1 and 2.2 gene expression after terpentine inflammation: Discordant responses to IL- 6
6. Binding of a growth hormone inducible nuclear factor is mediated by tyrosine phosphorylation
7. Activation of acute phase response factor (APRF)/Star 3 transcription factor by growth hormone
8. Specific inhibition of Stat 3 signal transduction by PIAS3
9. Tumor necrosis factor-α and fever after peripheral inflammation in the rat
10. Monocyte-conditioned medium, interleukin- 1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro
11. Juvenile rheumatoid arthritis: Effects of desease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin
12. Interleukin-1 beta suppresses growth hormone-induced mRNA levels and secretion in primary hepatocytes
13. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor
14. Defective inflammatory response in interleukin 6-deficient mice
15. The acute phase response of the liver in inflammation
16. Growth hormone and erythropoietin differentially activate DNA-Binding proteins by tyrosine phosphorylation
17. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation
18. Differential effects of thermal injury on circulating insulin-like growth factor binding proteins in burn patients
19. Acute nuclear actions of growth hormone (GH): Cycloheximide inhibits inducible activator protein-1 activity, but does not block GH-regulated signal transducer and activator of transcription activation or gene expression
20. In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of stat 3
21. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak 2 and Stat proteins
22. The role of GH receptor tyrosine phosphorylation in Stat 5 activation
23. Relationship of somatomedin-C/insulin-like growth factor I levels to conventional nutritional indices in critically ill patients
24. Interleukin- 6 and the acute phase response
25. Growth hormone action in hypothyroid infant rats
26. Growth hormone attenuates the acute-phase response to thermal injury
27. Increased exoression of insulin-like growth factor- 1 in serum and liver after recombinant human growth hormone administration in thermally injured rats
28. Dual signaling of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin- 6 cytokine receptors in hepatic cells
29. Distinct cytoplasmic domains of the growth hormone receptor are required for glucocorticoid- and phorbol ester-induced decreases in growth hormone (GH) binding. These domains are different from that reported for GH-induced receptor internalization
30. Acute-phase reactants: Their synthesis, turnover and biological significance
31. Biological perspectives of cytokine and hormone networks
32. Two separate signal transducer and activator of transcription proteins regulate transcription of the serine protease inhibitor- 3 gene in hepatic cells
33. The phenomenon of the acute phase response
34. The acute phase response: An overview
35. Insulin-like growth factor-1 activity is inhibited by interleukin-1α, tumor necrosis factor-α, and interleukin- 6
36. Inhibition of Stat1-mediated gene activation by PIAS 1
37. Transcriptional inhibition by Stat 5
38. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo
39. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation
40. The SOCS proteins: A new family of negative regulators of signal transduction
41. SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase
42. Molecular characterization of three rat liver serineprotease inhibitors affected by inflammation and hypophysectomy: Protein and mRNA analysis and cDNA cloning
43. Interferon γ-induced transcription of the high affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF 3
44. Reprioritization of liver protein synthesis resulting from recombinant human growth hormone supplementation in parenterally fed trauma patients: The effect of growth hormone on the acute-phase response
45. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation
46. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP- 1 and nuclear JAK2 tyrosine kinase
47. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors
48. Transcription factors Stat3 and Stat5b are present in rat liver nuclei late in an acute phase response and bind interleukin- 6 response elements
49. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I
50. Discoordinate hormonal and ontogenetic regulation of four rat serpin genes
51. Homologous rat hepatic protease inhibitor genes show divergent functional responses to inflammation
52. Differential expression of cytokine genes in monocytes, peritoneal macrophages and liver following endotoxin- or turpentine-induced inflammation in rat
53. Characterization and cloning of STAT5 from IM- 9 cells and its activation by growth hormone
54. Transcription of the rat serine protease inhibitor 2.1 gene in vivo: Correlation with GAGA box promoter occupancy and mechanism of cytokine-mediated down regulation
55. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH
56. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat 5A and Stat5B
57. A family of cytokine-inducible inhibitors of signalling
58. Increased mortality associated with growth hormone treatment in critically ill adults
59. Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
60. Growth hormone rapidly activates rat serine protease inhibitor 2.1 gene transcription and induces a DNA-binding activity distinct from those of Stat1, -3, and - 4
61. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat
62. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor
63. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level
64. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family
65. Proinflammatory cytokines interleukin 1β and tumor necrosis factorα, inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells
66. Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter
67. Mediation of growth hormone-dependent transcriptional activation by mammary gland factor Stat 5
68. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase
69. An inducible nuclear factor binds to a growth hormone-regulated gene
70. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
71. Stat 3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6